6657 — Energenesis Biomedical Co Cashflow Statement
0.000.00%
- TWD4.48bn
- TWD3.53bn
- TWD7.75m
Annual cashflow statement for Energenesis Biomedical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -129 | -120 | -266 | -260 | -231 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.07 | 3.18 | 7.38 | 4.9 | 2.54 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.52 | -3.13 | 1.04 | 6.61 | 25 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -98.9 | -97.3 | -233 | -225 | -181 |
| Capital Expenditures | -2.71 | -8.9 | -6.59 | -0.844 | -0.754 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 62.2 | -107 | 182 | -58.1 | 194 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 59.4 | -116 | 175 | -59 | 193 |
| Financing Cash Flow Items | — | 0.127 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.77 | 288 | -1.75 | 440 | 145 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -34.7 | 74.9 | -59.2 | 156 | 158 |